Due to the citywide ordinance, which went into effect last year, any pharma rep operating within the city for more than 15 days in a given year must be licensed through the city of Chicago. The licenses cost around $750 each.
“This milestone demonstrates our commitment to protecting residents when it comes to addictive drugs and holding drug representatives accountable if they seek to deceive, mislead or unduly influence the medical community,” Chicago Mayor Rahm Emanuel said.
The licensing protocol is a measure to protect people from “predatory marketing of prescription drugs,” according to a statement released from the mayor’s office. An additional 200 licenses are scheduled to go into effect come August due to Chicago’s ongoing federal opioid distributor lawsuit.
More articles on opioids:
27K deaths attributed to fentanyl and new synthetic opioids in 2017
BCBS report: Opioid prescriptions, diagnoses on the decline
3 drug distributors shipped 1.6B doses of opioids to Missouri in 5 years
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
